Hoya (OTCMKTS:HOCPY) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Hoya (OTCMKTS:HOCPY) from a sell rating to a hold rating in a report issued on Wednesday morning, Zacks.com reports.

According to Zacks, “Hoya Corporation is a specialty manufacturer of optical glass. The Company’s business activities include information technology, eye care, medical, and imaging systems. Its information technologies products include mask blanks and photomasks for semiconductor and LCD, glass memory disks, optical lenses, laser equipment and glass for electronic materials. Its eye care segment includes eyeglass lenses, contact lenses and intraocular lenses while the medical segment includes endoscopic imaging devices and hydroxyapatite. The Company’s imaging system offers digital cameras and CCTV lenses. It also offers system architecture, crystal products, surveying instruments. Hoya Corporation is based in Tokyo, Japan. “

Separately, Jefferies Financial Group downgraded Hoya from a buy rating to a hold rating in a research note on Wednesday, June 19th.

OTCMKTS:HOCPY opened at $79.36 on Wednesday. The firm has a market capitalization of $29.39 billion, a P/E ratio of 27.37, a price-to-earnings-growth ratio of 2.56 and a beta of 0.65. Hoya has a one year low of $51.60 and a one year high of $81.15. The stock has a 50-day moving average price of $75.99.

Hoya (OTCMKTS:HOCPY) last posted its quarterly earnings results on Tuesday, May 7th. The technology company reported $0.69 EPS for the quarter, missing the Zacks’ consensus estimate of $0.73 by ($0.04). Hoya had a return on equity of 20.75% and a net margin of 21.36%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.35 billion. Analysts predict that Hoya will post 3.01 earnings per share for the current year.

About Hoya

HOYA Corporation engages in the life care and information technology businesses. The company offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants.

See Also: What is the outlook for the FAANG stocks?

Get a free copy of the Zacks research report on Hoya (HOCPY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.